Breast Abnormalities Clinical Trial
Official title:
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
The primary hypothesis of this project is that using molecular breast imaging (MBI) in evaluating women with equivocal mammographic or sonographic findings will demonstrate high specificity in distinguishing benign from malignant breast disease and, as a result, decrease the number of biopsies.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01106911 -
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
|
N/A | |
| Active, not recruiting |
NCT02406274 -
Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities
|
N/A | |
| Terminated |
NCT00630318 -
Testing New Method of Analyzing MR Images
|
Phase 1 | |
| Completed |
NCT00722059 -
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
|
Phase 0 | |
| Withdrawn |
NCT00722683 -
Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts
|
N/A |